Trials / Terminated
TerminatedNCT02552732
Nasal High Flow Therapy 30 Day Readmission Study
Nasal High Flow (NHF) Therapy Use Following Hospitalization for an Exacerbation of COPD: A Feasibility Study
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Fisher and Paykel Healthcare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this feasibility study is to provide data for a subsequent randomized controlled trial to investigate if patient outcomes will be improved after an acute COPD exacerbation using domiciliary nasal high flow therapy (NHF) compared to standard care. This feasibility study will investigate the following: process, resources, management and scientific aspects of delivering NHF as an adjunct therapy in COPD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NHF with or without Oxygen | NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C. |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2017-05-03
- Completion
- 2017-05-03
- First posted
- 2015-09-17
- Last updated
- 2020-08-17
- Results posted
- 2020-07-24
Locations
2 sites across 2 countries: United States, New Zealand
Source: ClinicalTrials.gov record NCT02552732. Inclusion in this directory is not an endorsement.